Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gore

Showing results (161-170 of 314) with videos related to

Pageof 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Pegylated interferon alfa-2b treatment for patients with solid tumors: a phase I/II studyRonald Bukowski, Marc S Ernstoff, Martin E Gore, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The treatment of metastatic renal cell carcinoma by continuous intravenous infusion of recombinant interleukin-2M E Gore, E Galligioni, C W Keen, et al.
European Journal of Haematology. Supplementum|January 1, 1989
High-dose chemotherapy and autologous bone marrow transplantation for myelomaT J McElwain, P J Selby, M E Gore, et al.
Melanoma Research|March 29, 2006
Anti-alphaGal-dependent complement-mediated cytotoxicity in metastatic melanomaJames M G Larkin, Peter J Norsworthy, Roger P A'Hern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Natural history and prognosis of untreated stage I epithelial ovarian carcinomaF Y Ahmed, E Wiltshaw, R P A'Hern, et al.
The Journal of Antibiotics|April 1, 1977
LL-AM31 antibiotic complex: aminoalditol antibiotics from a StreptoverticilliumJ P Kirby, G E Van Lear, G O Morton, et al.
International Journal of Cosmetic Science|March 29, 2026
Evaluating the suitability of six hydrophobic natural eutectic solvents as the internal phase in a cosmetic cream formulationA Verger, R Grard, E Vrignaud, et al.
International Journal of Immunopharmacology|May 29, 1999
Atiprimod (SK&F 106615), a novel macrophage targeting agent, enhances alveolar macrophage candidacidal activity and is not immunosuppressive in Candida-infected miceA M Badger, J A Handler, C A Genell, et al.
British Journal of Cancer|January 1, 1997
Single-agent paclitaxel in patients with previously untreated stage IV epithelial ovarian cancer. London Gynaecological Oncology and North Thames Gynaecological Oncology GroupsM E Gore, G Rustin, M Slevin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
A randomised phase II study of carmustine alone or in combination with tumour necrosis factor in patients with advanced melanomaA L Jones, M E O'Brien, A Lorentzos, et al.
Pageof 32

Showing results (161-170 of 314) with videos related to

Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Pegylated interferon alfa-2b treatment for patients with solid tumors: a phase I/II studyRonald Bukowski, Marc S Ernstoff, Martin E Gore, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The treatment of metastatic renal cell carcinoma by continuous intravenous infusion of recombinant interleukin-2M E Gore, E Galligioni, C W Keen, et al.
European Journal of Haematology. Supplementum|January 1, 1989
High-dose chemotherapy and autologous bone marrow transplantation for myelomaT J McElwain, P J Selby, M E Gore, et al.
Melanoma Research|March 29, 2006
Anti-alphaGal-dependent complement-mediated cytotoxicity in metastatic melanomaJames M G Larkin, Peter J Norsworthy, Roger P A'Hern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Natural history and prognosis of untreated stage I epithelial ovarian carcinomaF Y Ahmed, E Wiltshaw, R P A'Hern, et al.
The Journal of Antibiotics|April 1, 1977
LL-AM31 antibiotic complex: aminoalditol antibiotics from a StreptoverticilliumJ P Kirby, G E Van Lear, G O Morton, et al.
International Journal of Cosmetic Science|March 29, 2026
Evaluating the suitability of six hydrophobic natural eutectic solvents as the internal phase in a cosmetic cream formulationA Verger, R Grard, E Vrignaud, et al.
International Journal of Immunopharmacology|May 29, 1999
Atiprimod (SK&F 106615), a novel macrophage targeting agent, enhances alveolar macrophage candidacidal activity and is not immunosuppressive in Candida-infected miceA M Badger, J A Handler, C A Genell, et al.
British Journal of Cancer|January 1, 1997
Single-agent paclitaxel in patients with previously untreated stage IV epithelial ovarian cancer. London Gynaecological Oncology and North Thames Gynaecological Oncology GroupsM E Gore, G Rustin, M Slevin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
A randomised phase II study of carmustine alone or in combination with tumour necrosis factor in patients with advanced melanomaA L Jones, M E O'Brien, A Lorentzos, et al.
Pageof 32